Current Radiopharmaceuticals
Volume 13, 3 Issues, 2020
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
Order Your Article Before Print
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
  |
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research
Aims & Scope
Current Radiopharmaceuticals publishes original research articles, letters, full-length/mini reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations, covering studies related to nuclear medicine, molecular imaging, radionuclide therapy, as radiology, oncology and radiotherapy and basic research. The scope of the journal also covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.
Current Radiopharmaceuticals
,Volume 13
-Number 1
Preface Open Access
Preface
Editorial Open Access
Imaging in Melanoma Management: What's New Under the Sun?
, 13(1): 3 - 5Pierpaolo Alongi*, Giuseppe Argenziano and Luigi Mansi*
DOI: 10.2174/187447101301200218111438
Imaging in Melanoma Management: What's New Under the Sun?
Review Article
Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers
, 13(1): 6 - 13Salvatore Annunziata*, Riccardo Laudicella, Federico Caobelli, Daniele A. Pizzuto and Young Aimn Working Group
DOI: 10.2174/1874471012666191015094620
Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers
Review Article
Malignant Cutaneous Melanoma: Updates in PET Imaging
, 13(1): 14 - 23Riccardo Laudicella*, Lucia Baratto, Fabio Minutoli, Sergio Baldari and Andrei Iagaru
DOI: 10.2174/1874471012666191015095550
Malignant Cutaneous Melanoma: Updates in PET Imaging
Review Article
The Role of PET/CT in the Era of Immune Checkpoint Inhibitors: State of Art
, 13(1): 24 - 31Angelo Castello and Egesta Lopci *
DOI: 10.2174/1874471012666191015100106
The Role of PET/CT in the Era of Immune Checkpoint Inhibitors: State of Art
Review Article Open Access
Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade
, 13(1): 32 - 41Natale Quartuccio*, Massimiliano Siracusa, Marco Pappalardo, Annachiara Arnone and Gaspare Arnone
DOI: 10.2174/1874471012666191015100837
Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade
Research Article
Clinical and Prognostic Value of 18F-FDG-PET/CT in the Restaging Process of Recurrent Cutaneous Melanoma
, 13(1): 42 - 47Domenico Albano, Demetrio Familiari, Maria C. Fornito, Salvatore Scalisi, Riccardo Laudicella, Massimo Galia, Emanuele Grassedonio, Antonella Ruggeri, Gloria Ganduscio, Marco Messina, Massimiliano Spada, Massimo Midiri and Pierpaolo Alongi*
DOI: 10.2174/1874471012666191009161826
Clinical and Prognostic Value of 18F-FDG-PET/CT in the Restaging Process of Recurrent Cutaneous Melanoma
Research Article Open Access
A Preliminary Study for Quantitative Assessment with HFUS (High- Frequency Ultrasound) of Nodular Skin Melanoma Breslow Thickness in Adults Before Surgery: Interdisciplinary Team Experience
, 13(1): 48 - 55Alfonso Reginelli*, Maria P. Belfiore, Anna Russo, Fabrizio Turriziani, Elvira Moscarella, Teresa Troiani, Gabriella Brancaccio, Andrea Ronchi, Emilio Giunta, Antonello Sica, Francesco Iovino, Fortunato Ciardiello, Renato Franco, Giuseppe Argenziano, Roberto Grassi and Salvatore Cappabianca
DOI: 10.2174/1874471012666191007121626
A Preliminary Study for Quantitative Assessment with HFUS (High- Frequency Ultrasound) of Nodular Skin Melanoma Breslow Thickness in Adults Before Surgery: Interdisciplinary Team Experience
Articles Ahead of Print
Experimental Breast Cancer Models: Preclinical Imaging Perspective
Ulku Korkmaz* and Funda Ustun
DOI: 10.2174/1874471013666200508080250
View Abstract View on PubMed
Analysis of Cell Fraction of 99mTc-HMPAO Radiolabeled Leukocytes
Eun-Mi Kim, Hwan-Jeong Jeong*, Seok-Tae Lim and Myung-Hee Sohn
DOI: 10.2174/1874471013666200510015742
View Abstract View on PubMed
In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
Vilde Yuli Stenberg, Asta Juzeniene*, Øyvind Sverre Bruland and Roy Hartvig Larsen
DOI: 10.2174/1874471013666200511000532
View Abstract View on PubMed
Lung Cancer And Radiological Imaging
Annalori Panunzio* and Paolo Sartori
DOI: 10.2174/1874471013666200523161849
View Abstract
Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies
Selin Yılmaz, Çiğdem İçhedef, Kadriye Buşra Karatay and Serap Teksöz*
DOI: 10.2174/1874471013666200430094113
View Abstract View on PubMed
Animal Models for the Evaluation of Theranostic Radiopharmaceuticals
Selin Soyluoglu* and Gulay Durmus-Altun
DOI: 10.2174/1874471013666200425223428
View Abstract View on PubMed
Physiological Animal Imaging with 68Ga-Citrate
Ayşe Uğur and Aziz Gültekin*
DOI: 10.2174/1874471013666200421114031
View Abstract View on PubMed
The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis
Assuero Giorgetti*, Dario Genovesi and Michele Emdin
DOI: 10.2174/1874471013666200422102406
View Abstract View on PubMed
Emerging molecular targets for imaging of atherosclerotic plaque using positron emission tomography
Rudolf A. Werner, Frank M. Bengel and Thorsten Derlin*
DOI: 10.2174/1874471013666200505102353
View Abstract
The Multicenter Italian Trial Assesses the Performance of FDG-PET/CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy
Marco Spadafora*, Laura Evangelista, Salvatore Fiordoro, Francesco Porcaro, Marilena Sicignano and Luigi Mansi
DOI: 10.2174/1874471013666200318142210
View Abstract View on PubMed
Abstracts Ahead of Print
There are currently no Abstracts Ahead of Print available for this journal.
Published Contents
- Current Radiopharmaceuticals, Volume 13, 2020
- Current Radiopharmaceuticals, Volume 12, 2019
- Current Radiopharmaceuticals, Volume 11, 2018
- Current Radiopharmaceuticals, Volume 10, 2017
- Current Radiopharmaceuticals, Volume 9, 2016
- Current Radiopharmaceuticals, Volume 8, 2015
- Current Radiopharmaceuticals, Volume 7, 2014
- Current Radiopharmaceuticals, Volume 6, 2013
- Current Radiopharmaceuticals, Volume 5, 2012
- Current Radiopharmaceuticals, Volume 4, 2011
- Current Radiopharmaceuticals, Volume 3, 2010
- Current Radiopharmaceuticals, Volume 2, 2009
- Current Radiopharmaceuticals, Volume 1, 2008
Editor's Choice
New 99mTc Radiotracers for Myocardial Perfusion Imaging by SPECT
, 2019; 12(3): 171 - 186Wei Fang* and Shuang Liu*
DOI: 10.2174/1874471012666190206102214
68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers
, 2019; 12(3): 238 - 246Ferdinando Calabria*, Robert Pichler, Mario Leporace, Johannes Wolfsgruber, Pierluigi Coscarelli, Andreas Dunzinger, Orazio Schillaci, Giuseppe Lucio Cascini and Antonio Bagnato
DOI: 10.2174/1874471012666190515090755
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours
, 2019; 12(2): 98 - 106Vincenzo Cuccurullo*, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190206094555
[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations
, 2019; 12(1): 58 - 71Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*
DOI: 10.2174/1874471012666190102165053
The Production of Ac-225
, 2018; 11(3): 173 - 179Jonathan W. Engle*
DOI: 10.2174/1874471011666180418141357
NorthStar Perspectives for Actinium-225 Production at Commercial Scale
, 2018; 11(3): 180 - 191James T. Harvey*
DOI: 10.2174/1874471011666180515123848
Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?
, 2018; 11(2): 123 - 129Mohammed Al-Qahtani, Yousif Al Malki, Hadeel Mutwali, Edward Helal-Neto and Ralph Santos-Oliveira*
DOI: 10.2174/1874471011666180418110206
Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy
, 2018; 11(1): 34 - 45Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa
DOI: 10.2174/1874471011666171229123130
Personalized & Precision Medicine in Cancer: A Theranostic Approach
, 2017; 10(3): 166 - 170Partha Choudhury* and Manoj Gupta
DOI: 10.2174/1874471010666170728094008
PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical Perspectives
, 2017; 10(3): 184 - 194Giampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello*
DOI: 10.2174/1874471010666170816125051
Open Access Articles
Comparison of 99mTc Injected Activity with Prescribed Activity in Four Types of Nuclear Medicine Exams
, 2020; 13(1): 80 - 85Muhammad Isa Khan, Umme Farwa, Tahir Iqbal, Saadat Ali, Aalia Nazir and Mohsin Ijaz*
Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications
, 2020; 13(1): 63 - 79Sara Pastorino, Mattia Riondato, Licia Uccelli, Giampiero Giovacchini, Elisabetta Giovannini, Valerio Duce and Andrea Ciarmiello*
Ileal Melanoma, A Rare Cause of Small Bowel Obstruction: Report of a Case, and Short Literature Review
, 2020; 13(1): 56 - 62Emanuele Sinagra * and Carmelo Sciumè
A Preliminary Study for Quantitative Assessment with HFUS (High- Frequency Ultrasound) of Nodular Skin Melanoma Breslow Thickness in Adults Before Surgery: Interdisciplinary Team Experience
, 2020; 13(1): 48 - 55Alfonso Reginelli*, Maria P. Belfiore, Anna Russo, Fabrizio Turriziani, Elvira Moscarella, Teresa Troiani, Gabriella Brancaccio, Andrea Ronchi, Emilio Giunta, Antonello Sica, Francesco Iovino, Fortunato Ciardiello, Renato Franco, Giuseppe Argenziano, Roberto Grassi and Salvatore Cappabianca
Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade
, 2020; 13(1): 32 - 41Natale Quartuccio*, Massimiliano Siracusa, Marco Pappalardo, Annachiara Arnone and Gaspare Arnone
PET/CT and the Response to Immunotherapy in Lung Cancer
, 2020; 13: 1 - 8 (E-Pub Ahead of Print)Evangelista Laura*, Matteo Sepulcri and Giulia Pasello
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
, 2020; 13: 1 - 11 (E-Pub Ahead of Print)Vittorio Briganti, Vincenzo Cuccurullo*, Valentina Berti, Giuseppe Danilo Di Stasio, Flavia Linguanti, Francesco Mungai and Luigi Mansi
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
, 2020; 13: 1 - 10 (E-Pub Ahead of Print)Angelo Castello , Sabrina Rossi and Egesta Lopci *
Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions
, 2020; 13: 1 - 10 (E-Pub Ahead of Print)Luca Guerra* and Crivellaro Cinzia
The Multicenter Italian Trial Assesses the Performance of FDG-PET/CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy
, 2020; 13: 1 - 6 (E-Pub Ahead of Print)Marco Spadafora*, Laura Evangelista, Salvatore Fiordoro, Francesco Porcaro, Marilena Sicignano and Luigi Mansi
Radiotherapy Planning and Molecular Imaging in Lung Cancer
, 2020; 13: 1 - 14 (E-Pub Ahead of Print)Angelina Filice*, Massimiliano Casali, Patrizia Ciammella, Marco Galaverni, Federica Fioroni, Cinzia Iotti and Annibale Versari
The Screening of Renoprotective Agents by 99mTc-DMSA: A Review of Preclinical Studies
, 2019; 12(3): 211 - 219Masoud Rezaei , Maryam Papie, Mohsen Cheki*, Luigi Mansi, Sean Kitson and Amirhossein Ahmadi
Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries
, 2019; 12(3): 187 - 200Efrain Araujo Perini *, Mikhail Skopchenko, Tran Thu Hong , Rahmat Harianto , Alexis Maître, Maidelys Rosa Rodríguez Rodríguez , Nathalia de Oliveira Santos , Yinglei Guo, Xiangyu Qin , Carlos A. Zeituni and Valeriia N. Starovoitova
[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations
, 2019; 12(1): 58 - 71Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*
Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level
, 2019; 12(1): 40 - 48Ingrid Kreimerman, Erick Mora-Ramirez, Laura Reyes, Manuel Bardiès, Eduardo Savio* and Henry Engler
Most Cited Articles
Research Article
Biochemical and histopathological evaluation of the radioprotective effects of melatonin against gamma ray-induced skin damage
, 2019; 12(1): 72-81.Dheyauldeen Shabeeb, Masoud Najafi, Ahmed Eleojo Musa, Mansoor Keshavarz, Alireza Shirazi*, Gholamreza Hassanzadeh*, Mohammed Reza Hadian and Hedayat Samandari
DOI: 10.2174/1874471012666181120163250
Review Article
State of the art and recent developments of radiopharmaceuticals for pancreatic neuroendocrine tumors imaging
, 2019; 12(2): 107-125.Angela Carollo*, Stefano Papi, Chiara M. Grana, Luigi Mansi and Marco Chinol
DOI: 10.2174/1874471012666190306104450
Research Article
Evaluating the radioprotective effect of curcumin on rat’s heart tissues
, 2019; 12(1): 23-28.Sedighe Kolivand, Peyman Amini, Hana Saffar, Saeed Rezapoor, Elahe Motevaseli*, Masoud Najafi*, Farzad Nouruzi, Dheyauldeen Shabeeb and Ahmed Eleojo Musa
DOI: 10.2174/1874471011666180831101459
Research Article
A preliminary study for quantitative assessment with HFUS (High-frequency ultrasound) of nodular skin melanoma breslow thickness in adults before surgery: Interdisciplinary team experience
, 2019; 13(1): 48-55.Alfonso Reginelli*, Maria P. Belfiore, Anna Russo, Fabrizio Turriziani, Elvira Moscarella, Teresa Troiani, Gabriella Brancaccio, Andrea Ronchi, Emilio Giunta, Antonello Sica, Francesco Iovino, Fortunato Ciardiello, Renato Franco, Giuseppe Argenziano, Roberto Grassi and Salvatore Cappabianca
DOI: 10.2174/1874471012666191007121626
Research Article
Evaluation of the radioprotective effects of melatonin against ionizing radiation-induced muscle tissue injury
, 2019; 12(3): 247-255.Dheyauldeen Shabeeb, Mansoor Keshavarz , Alireza Shirazi*, Gholamreza Hassanzadeh*, Mohammed Reza Hadian, Azin Nowrouzi, Masoud Najafi* and Ahmed Eleojo Musa
DOI: 10.2174/1874471012666190219120329
Review Article
O-(2-[<sup>18</sup>F]-Fluoroethyl)-l-tyrosine (FET) in neurooncology: A review of experimental results
, 2019; 12(3): 201-210.Carina Stegmayr, Antje Willuweit, Philipp Lohmann and Karl-Josef Langen*
DOI: 10.2174/1874471012666190111111046
Perspective
PET/MRI in neuroendocrine tumours: Blessings and curses
, 2019; 12(2): 96-97.Mapelli Paola, De Cobelli F and Maria Picchio
DOI: 10.2174/1874471012999190404151701
Review Article
Physiopathological premises to nuclear medicine imaging of pancreatic neuroendocrine tumours
, 2019; 12(2): 98-106.Vincenzo Cuccurullo*, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190206094555
Research Article
Determination of gamma camera’s calibration factors for quantitation of diagnostic radionuclides in simultaneous scattering and attenuation correction
, 2019; 12(1): 29-39.Afrouz Asgari, Mansour Ashoor, Leila Sarkhosh, Abdollah Khorshidi* and Parvaneh Shokrani
DOI: 10.2174/1874471011666180914095222
Research Article
Feasibility and evaluation of automated methods for radiolabeling of radiopharmaceutical kits with gallium-68
, 2019; 12(3): 229-237.Alban Revy, François Hallouard*, Sandrine Joyeux-Klamber, Andrea Skanjeti, Catherine Rioufol and Marc Fraysse
DOI: 10.2174/1874471012666190110170623
Review Article
Peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours
, 2019; 12(2): 126-134.Shahad Alsadik, Siraj Yusuf and Adil AL-Nahhas*
DOI: 10.2174/1874471012666190201164132
Review Article
Utility of molecular imaging with 2-deoxy-2-[fluorine-18] fluoro-d-glucose positron emission tomography (<sup>18</sup> F-FDG PET) for small cell lung cancer (SCLC): A radiation oncology perspective
, 2019; 12(1): 4-10.Omer Sager*, Ferrat Dincoglan, Selcuk Demiral, Bora Uysal, Hakan Gamsiz, Yelda Elcim, Esin Gundem, Bahar Dirican and Murat Beyzadeoglu
DOI: 10.2174/1874471012666181120162434
Review Article
The role of PET/CT in the era of immune checkpoint inhibitors: State of art
, 2019; 13(1): 24-31.Angelo Castello and Egesta Lopci *
DOI: 10.2174/1874471012666191015100106
Research Article
Clinical and prognostic value of<sup>18</sup>F-FDG-PET/CT in the restaging process of recurrent cutaneous melanoma
, 2020; 13(1): 42-47.Domenico Albano, Demetrio Familiari, Maria C. Fornito, Salvatore Scalisi, Riccardo Laudicella, Massimo Galia, Emanuele Grassedonio, Antonella Ruggeri, Gloria Ganduscio, Marco Messina, Massimiliano Spada, Massimo Midiri and Pierpaolo Alongi*
DOI: 10.2174/1874471012666191009161826
Review Article
Sentinel node identification in melanoma: Current clinical impact, new emerging SPECT radiotracers and technological advancements. an update of the last decade
, 2020; 13(1): 32-41.Natale Quartuccio*, Massimiliano Siracusa, Marco Pappalardo, Annachiara Arnone and Gaspare Arnone
DOI: 10.2174/1874471012666191015100837
Most Accessed Articles
Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications
, 2020; 13(1): 63-79.Sara Pastorino, Mattia Riondato, Licia Uccelli, Giampiero Giovacchini, Elisabetta Giovannini, Valerio Duce and Andrea Ciarmiello*
DOI: 10.2174/1874471012666190729151540
The Role of PET/CT in the Era of Immune Checkpoint Inhibitors: State of Art
, 2020; 13(1): 24-31.Angelo Castello and Egesta Lopci *
DOI: 10.2174/1874471012666191015100106
Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade
, 2020; 13(1): 32-41.Natale Quartuccio*, Massimiliano Siracusa, Marco Pappalardo, Annachiara Arnone and Gaspare Arnone
DOI: 10.2174/1874471012666191015100837
New 99mTc Radiotracers for Myocardial Perfusion Imaging by SPECT
, 2019; 12(3): 171-186.Wei Fang* and Shuang Liu*
DOI: 10.2174/1874471012666190206102214
Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy
, 2008; 1(3): 203-208.Oyvind S. Bruland, Thora J. Jonasdottir, Darrell R. Fisher and Roy H. Larsen
DOI: 10.2174/1874471010801030203
Ileal Melanoma, A Rare Cause of Small Bowel Obstruction: Report of a Case, and Short Literature Review
, 2020; 13(1): 56-62.Emanuele Sinagra * and Carmelo Sciumè
DOI: 10.2174/1874471012666191015101410
A Preliminary Study for Quantitative Assessment with HFUS (High- Frequency Ultrasound) of Nodular Skin Melanoma Breslow Thickness in Adults Before Surgery: Interdisciplinary Team Experience
, 2020; 13(1): 48-55.Alfonso Reginelli*, Maria P. Belfiore, Anna Russo, Fabrizio Turriziani, Elvira Moscarella, Teresa Troiani, Gabriella Brancaccio, Andrea Ronchi, Emilio Giunta, Antonello Sica, Francesco Iovino, Fortunato Ciardiello, Renato Franco, Giuseppe Argenziano, Roberto Grassi and Salvatore Cappabianca
DOI: 10.2174/1874471012666191007121626
Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma
, 2018; 11(1): 14-21.Natasha Alexander, Reza Vali, Hojjat Ahmadzadehfar, Amer Shammas and Sylvain Baruchel*
DOI: 10.2174/1874471011666171215093112
Editor-in-Chief
Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
(Northern Ireland)
Biography
View Full Editorial Board
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
Biography
Biography of Sean L. Kitson
Dr Kitson is an Investigator of Radiochemistry at Almac, UK. He has over 15 years of experience in the synthesis of carbon-14 labelled compounds. Dr Kitson is the Editor-in-Chief of Current Radiopharmaceuticals published by Bentham Science Publishers and the Journal of Diagnostic Imaging in Therapy. He has published over 45 research, reviews and commercial articles in the area of carbon-14 synthesis and medical imaging. His contribution to radiochemistry was acknowledged by winning the 2006 Wiley Journal of Labelled Compounds and Radiopharmaceuticals Young Scientists Award. Since, 2007 he has been a Member of the Scientific Committee for the International Isotopes Society (IIS) UK group.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Radiopharmaceuticals Journal was launched in 2008. Dr. Sean L. Kitson serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.77
Advertisement
Webmaster Contact: info@benthamscience.net